Profile data is unavailable for this security.
About the company
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
- Revenue in SEK (TTM)0.00
- Net income in SEK-41.60m
- Incorporated1983
- Employees8.00
- LocationActive Biotech AB publScheelevagen 22LUND 223 63SwedenSWE
- Phone+46 46192000
- Fax+46 46191105
- Websitehttps://www.activebiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SenzaGen AB | -100.00bn | -100.00bn | 210.95m | 33.00 | -- | 2.36 | -- | -- | -- | -- | -- | 3.03 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 3.18 | -- | 0.0225 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Lifecare ASA | 15.02m | -59.65m | 212.55m | 32.00 | -- | 0.183 | -- | 14.15 | -16.49 | -16.49 | 1.51 | 73.51 | 0.1698 | -- | 1.56 | 471,007.80 | -67.36 | -40.00 | -86.96 | -45.26 | -- | -- | -396.68 | -175.53 | -- | -- | 0.1102 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Abliva AB | 137.00k | -102.13m | 214.38m | 6.00 | -- | 2.08 | -- | 1,564.82 | -0.0928 | -0.0928 | 0.0001 | 0.0638 | 0.0013 | -- | 0.0062 | 22,833.33 | -93.81 | -74.59 | -103.87 | -86.98 | -35,826.28 | -- | -74,542.34 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -52.45m | 250.50m | 4.00 | -- | 9.99 | -- | -- | -0.1734 | -0.1734 | 0.00 | 0.0471 | 0.00 | -- | -- | 0.00 | -235.29 | -125.42 | -407.84 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -87.20m | 253.27m | 6.00 | -- | 3.92 | -- | -- | -8.16 | -8.16 | 0.00 | 5.25 | 0.00 | -- | -- | -- | -96.71 | -69.56 | -117.53 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
| Ascelia Pharma AB | 0.00 | -62.30m | 260.38m | 13.00 | -- | 2.45 | -- | -- | -1.12 | -1.12 | 0.00 | 1.11 | 0.00 | -- | -- | 0.00 | -46.53 | -- | -56.96 | -- | -- | -- | -- | -- | -- | -10.21 | 0.1983 | -- | -- | -- | 16.72 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -41.60m | 271.34m | 8.00 | -- | 143.09 | -- | -- | -0.0644 | -0.0644 | 0.00 | 0.0018 | 0.00 | -- | -- | -- | -284.93 | -57.97 | -1,027.16 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.5758 | -- | -- | -- | 21.54 | -- | -- | -- |
| Xbrane Biopharma AB | 199.81m | -304.77m | 294.58m | 65.00 | -- | 1.13 | -- | 1.47 | -0.7304 | -0.9784 | 0.2266 | 0.1701 | 0.2309 | 0.4396 | 5.01 | 2,148,473.00 | -35.22 | -40.98 | -70.65 | -67.24 | 61.87 | -- | -152.53 | -364.40 | 0.8986 | -8.52 | 0.3957 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
| Medivir AB | 6.93m | -116.92m | 303.97m | 10.00 | -- | 2.14 | -- | 43.84 | -1.42 | -1.42 | 0.0735 | 1.26 | 0.0365 | -- | 1.31 | 693,300.00 | -61.49 | -28.91 | -81.28 | -34.77 | -1,300.04 | -467.42 | -1,686.46 | -675.96 | -- | -- | 0.0628 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
| Herantis Pharma Oyj | 0.00 | -7.04m | 306.01m | 11.00 | -- | 13.05 | 12.83 | -- | -0.0146 | -0.0146 | 0.00 | 0.1012 | 0.00 | -- | -- | 0.00 | -13.93 | -80.46 | -27.32 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0145 | -- | -- | -- | 103.00 | -- | -- | -- |
| Oncopeptides AB | 27.07m | -282.39m | 324.14m | 79.00 | -- | 2.39 | -- | 11.97 | -1.94 | -1.94 | 0.1763 | 0.6421 | 0.0882 | 0.8441 | 0.6929 | 474,929.80 | -91.96 | -141.28 | -107.34 | -200.49 | 89.97 | -- | -1,043.16 | -2,689.06 | 6.16 | -199.53 | 0.5030 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
| Saniona AB | 24.88m | -81.81m | 325.03m | 22.00 | -- | 46.60 | -- | 13.06 | -0.9821 | -0.9821 | 0.2822 | 0.0623 | 0.2386 | -- | 6.23 | 1,081,652.00 | -78.47 | -59.16 | -168.78 | -70.15 | -92.01 | -970.05 | -328.83 | -1,483.55 | -- | -3.03 | 0.8668 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| Alzinova AB | 300.00k | -18.72m | 331.70m | 5.00 | -- | 2.54 | -- | 1,105.65 | -0.3144 | -0.3144 | 0.0048 | 1.46 | 0.0023 | -- | 0.4478 | 60,000.00 | -14.06 | -10.77 | -14.94 | -11.27 | -2,642.00 | -- | -6,240.33 | -18,447.90 | -- | -172.34 | 0.0061 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Cantargia AB | 0.00 | -193.53m | 332.84m | 21.00 | -- | 6.80 | -- | -- | -1.07 | -1.07 | 0.00 | 0.2664 | 0.00 | -- | -- | 0.00 | -121.74 | -55.08 | -165.80 | -61.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.69 | -- | -- | -- |
| Hamlet BioPharma AB | 0.00 | -41.82m | 334.74m | 7.00 | -- | 6.82 | -- | -- | -0.2756 | -0.2756 | 0.00 | 0.3842 | 0.00 | -- | -- | 0.00 | -86.17 | -80.47 | -92.51 | -97.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -104.57 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Active Biotech AB publ's reporting currency: Swedish Krona SEK
4.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 30 Jun 2024 | 37.75m | 3.48% |
| Skandia Investment Management ABas of 30 Sep 2024 | 4.07m | 0.38% |
| SEB Investment Management ABas of 31 Oct 2024 | 3.52m | 0.32% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 2.03m | 0.19% |
| FCG Fonder ABas of 31 Oct 2024 | 1.11m | 0.10% |
| Storebrand Asset Management ASas of 30 Sep 2024 | 311.37k | 0.03% |
More ▼
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
